Zions Bancorporation NA
ZION · NASDAQ
About ZION
- Employees
- 9,195
- Headquarters
- Salt Lake City, Utah
- Listed
- Jan 1, 1966
- Sector
- Financials
- Industry
- Banks
- Website
- zionsbancorporation.com
ZION key statistics
- Market cap
- 10.14B
- Price-earnings ratio
- 0.00
- Dividend yield
- 3.05%
- Average volume
- 1.45M
- Volume
- 3.39M
- Open price
- $63.21
- High today
- $65.62
- Low today
- $63.21
- 52 Week high
- $73.34
- 52 Week low
- $48.50
Zions Bancorporation NA (ZION) at a glance
As of Oct 20, 2026, Zions Bancorporation NA (ZION) shares are priced at $64.59, giving the company a market cap of 10.14B, a price-to-earnings ratio of 0.00 and a dividend yield of 3.05%.
Today the stock has traded between $63.21 and $65.62. The current price is 2.2% above the day's low and 1.6% below its high.
Volume so far is 3.39M shares, above the average of 1.45M shares a day.
Over the past year Zions Bancorporation NA has ranged from $48.50 to $73.34, and now sits 65% of the way up that range.
Zions Bancorporation NA met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q3 FY26 it reported $1.78 per share against an estimate of $1.70.
The average analyst price target is $76.11, 17.8% above the current price, from 19 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy31.6%
- Hold47.4%
- Sell21.1%
- Low
- $65.65
- Now
- $64.59
- High
- $88.20
ZION earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 16.7% on average.
- Q4 FY24: reported $1.34 per share against an estimate of $1.28
- Q1 FY25: reported $1.13 per share against an estimate of $1.21
- Q2 FY25: reported $1.63 per share against an estimate of $1.34
- Q3 FY25: reported $1.48 per share against an estimate of $1.44
- Q4 FY25: reported $1.76 per share against an estimate of $1.59
- Q1 FY26: reported $1.56 per share against an estimate of $1.45
- Q2 FY26: reported $3.05 per share against an estimate of $1.85
- Q3 FY26: reported $1.78 per share against an estimate of $1.70
ZION news
- Press releasePRNewswire
- Press releasePRNewswire
Zions Bancorporation, National Association Reports Third Quarter Financial Results
- Press releasePRNewswire
ZIONS CAPITAL MARKETS APPOINTS VINCE TOYE TO LEAD NEWLY ACQUIRED AGENCY MULTIFAMILY LENDING PLATFORM
- Press releasePRNewswire
ZIONS BANCORPORATION TO PRESENT AT THE BARCLAYS GLOBAL FINANCIAL SERVICES CONFERENCE
- Press releasePRNewswire
Westlake Securities Secures Expanded Senior Credit Facility for SolvChem with Amegy Bank
- Press releasePRNewswire
ZIONS BANCORPORATION COMPLETES ACQUISITION OF FANNIE MAE AND FREDDIE MAC MULTIFAMILY BUSINESS LINE FROM BASIS INVESTMENT GROUP
- Press releasePRNewswire
ZIONS BANCORPORATION'S BOARD ANNOUNCES APPROVAL OF SHARE REPURCHASE AND DECLARES DIVIDENDS ON COMMON AND PREFERRED STOCK
- Press releasePRNewswire
ZIONS BANCORPORATION ANNOUNCES PRICING OF SENIOR NOTES
Similar companies
Companies in the same industry as Zions Bancorporation NA
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.